Mackenzie Financial Corp Boston Scientific Corp Transaction History
Mackenzie Financial Corp
- $71.6 Billion
- Q2 2025
A detailed history of Mackenzie Financial Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Mackenzie Financial Corp holds 1,603,611 shares of BSX stock, worth $164 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
1,603,611
Previous 771,339
107.9%
Holding current value
$164 Million
Previous $77.8 Million
121.36%
% of portfolio
0.24%
Previous 0.12%
Shares
30 transactions
Others Institutions Holding BSX
# of Institutions
1,934Shares Held
1.27BCall Options Held
9.59MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA137MShares$14 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.9 Billion0.22% of portfolio
-
State Street Corp Boston, MA65.2MShares$6.68 Billion0.27% of portfolio
-
Primecap Management CO Pasadena, CA34.7MShares$3.55 Billion3.04% of portfolio
-
Bank Of America Corp Charlotte, NC33.8MShares$3.47 Billion0.27% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $147B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...